Cargando…
Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
BACKGROUND: Without organized screening programs up to 60-70% of breast cancers are diagnosed at advanced stages that have significantly lower five-year survival rate and poorer outcomes, which is a serious global public health problem. The purpose of the blind clinical study was the assessment of t...
Autores principales: | Sekacheva, Marina, Boroda, Alexander, Fatyanova, Anastasia, Rozhkov, Alexander, Bagmet, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189101/ https://www.ncbi.nlm.nih.gov/pubmed/37207139 http://dx.doi.org/10.3389/fonc.2023.1009863 |
Ejemplares similares
-
Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022) -
Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors
por: Poddubskaya, Elena, et al.
Publicado: (2019) -
Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma
por: Voronova, Veronika, et al.
Publicado: (2020) -
Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors
por: Ngaha, Tchawe Yvan Sinclair, et al.
Publicado: (2023) -
CLIA-certified next-generation sequencing analysis in the cloud
por: Zhang, Ying, et al.
Publicado: (2012)